These are the sources and citations used to research microrna. This bibliography was generated on Cite This For Me on

  • Journal

    Faraldi, M., Gomarasca, M., Sansoni, V., Perego, S., Banfi, G. and Lombardi, G.

    Normalization strategies differently affect circulating miRNA profile associated with the training status

    2019 - Scientific Reports

    In-text: (Faraldi et al.)

    Your Bibliography: Faraldi, Martina et al. "Normalization Strategies Differently Affect Circulating Mirna Profile Associated With The Training Status." Scientific Reports 9.1 (2019): n. pag. Web.

  • Journal

    Gallo Cantafio, M. E., Nielsen, B. S., Mignogna, C., Arbitrio, M., Botta, C., Frandsen, N. M., Rolfo, C., Tagliaferri, P., Tassone, P. and Di Martino, M. T.

    Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates

    2016 - Molecular Therapy - Nucleic Acids

    In-text: (Gallo Cantafio et al. e326)

    Your Bibliography: Gallo Cantafio, Maria Eugenia et al. "Pharmacokinetics And Pharmacodynamics Of A 13-Mer LNA-Inhibitor-Mir-221 In Mice And Non-Human Primates." Molecular Therapy - Nucleic Acids 5 (2016): e326. Web.

  • Journal

    Garzon, R., Marcucci, G. and Croce, C. M.

    Targeting MicroRNAs in Cancer: Rationale, Strategies and Challenges

    2010 - Nat Rev Drug Discov

    In-text: (Garzon, Marcucci and Croce 775-789)

    Your Bibliography: Garzon, Ramiro, Guido Marcucci, and Carlo M Croce. "Targeting Micrornas In Cancer: Rationale, Strategies And Challenges." Nat Rev Drug Discov 9.10 (2010): 775-789. Web. 18 Nov. 2019.

  • Journal

    Hoey, C., Ahmed, M., Fotouhi Ghiam, A., Vesprini, D., Huang, X., Commisso, K., Commisso, A., Ray, J., Fokas, E., Loblaw, D. A., He, H. H. and Liu, S. K.

    Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy

    2019 - Journal of Translational Medicine

    In-text: (Hoey et al.)

    Your Bibliography: Hoey, C. et al. "Circulating Mirnas As Non-Invasive Biomarkers To Predict Aggressive Prostate Cancer After Radical Prostatectomy." Journal of Translational Medicine 17.1 (2019): n. pag. Web.

  • Journal

    Hutvágner, G., Simard, M. J., Mello, C. C. and Zamore, P. D.

    Sequence-Specific Inhibition of Small RNA Function

    2004 - PLoS Biology

    In-text: (Hutvágner et al. e98)

    Your Bibliography: Hutvágner, György et al. "Sequence-Specific Inhibition Of Small RNA Function." PLoS Biology 2.4 (2004): e98. Web.

  • Journal


    MicroRNA expression profiling in canine prostate cancer

    2017 - Journal of Veterinary Medical Science

    In-text: (KOBAYASHI et al. 719-725)

    Your Bibliography: KOBAYASHI, Masanori et al. "Microrna Expression Profiling In Canine Prostate Cancer." Journal of Veterinary Medical Science 79.4 (2017): 719-725. Web.

  • Journal

    Polakovičová, M., Musil, P., Laczo, E., Hamar, D. and Kyselovič, J.

    Circulating MicroRNAs as Potential Biomarkers of Exercise Response

    2016 - International Journal of Molecular Sciences

    In-text: (Polakovičová et al. 1553)

    Your Bibliography: Polakovičová, Mája et al. "Circulating Micrornas As Potential Biomarkers Of Exercise Response." International Journal of Molecular Sciences 17.10 (2016): 1553. Web.

  • Journal

    Setoguchi, K., Cui, L., Hachisuka, N., Obchoei, S., Shinkai, K., Hyodo, F., Kato, K., Wada, F., Yamamoto, T., Harada-Shiba, M., Obika, S. and Nakano, K.

    Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes

    2017 - Molecular Therapy - Nucleic Acids

    In-text: (Setoguchi et al. 170-181)

    Your Bibliography: Setoguchi, Kiyoko et al. "Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis By Downregulating Bcl-Xl-VEGFR2/-Tie Axes." Molecular Therapy - Nucleic Acids 9 (2017): 170-181. Web.

  • Journal

    Shimojo, M., Kasahara, Y., Inoue, M., Tsunoda, S., Shudo, Y., Kurata, T. and Obika, S.

    A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer

    2019 - Scientific Reports

    In-text: (Shimojo et al.)

    Your Bibliography: Shimojo, Masahito et al. "A Gapmer Antisense Oligonucleotide Targeting SRRM4 Is A Novel Therapeutic Medicine For Lung Cancer." Scientific Reports 9.1 (2019): n. pag. Web.

  • Journal

    Song, M., Pan, K., Su, H., Zhang, L., Ma, J., Li, J., Yuasa, Y., Kang, D., Kim, Y. S. and You, W.

    Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer

    2012 - PLoS ONE

    In-text: (Song et al. e33608)

    Your Bibliography: Song, Ming-yang et al. "Identification Of Serum Micrornas As Novel Non-Invasive Biomarkers For Early Detection Of Gastric Cancer." PLoS ONE 7.3 (2012): e33608. Web.

  • Journal

    Theodore, S., Davis, M., Zhao, F., Wang, H., Chen, D., Rhim, J., Dean-Colomb, W., Turner, T., Ji, W., Zeng, G., Grizzle, W. and Yates, C.

    MicroRNAprofiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1

    2014 - Oncotarget

    In-text: (Theodore et al. 3512-25)

    Your Bibliography: Theodore, SC et al. "Micrornaprofiling Of Novel African American And Caucasian Prostate Cancer Cell Lines Reveals A Reciprocal Regulatory Relationship Of Mir-152 And DNA Methyltranferase 1." Oncotarget 15;5.11 (2014): 3512-25. Web. 18 Nov. 2019.

  • Journal

    von Deetzen, M., Schmeck, B. T., Gruber, A. D. and Klopfleisch, R.

    Malignancy Associated MicroRNA Expression Changes in Canine Mammary Cancer of Different Malignancies

    2014 - ISRN Veterinary Science

    In-text: (von Deetzen et al. 1-5)

    Your Bibliography: von Deetzen, Marie-Charlotte et al. "Malignancy Associated Microrna Expression Changes In Canine Mammary Cancer Of Different Malignancies." ISRN Veterinary Science 2014 (2014): 1-5. Web.

  • Journal

    Xu, S., Li, J., Chen, L., Guo, L., Ye, M., Wu, Y. and Ji, Q.

    Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy

    2019 - Medicine

    In-text: (Xu et al. e17335)

    Your Bibliography: Xu, Shuyuan et al. "Plasma Mir-32 Levels In Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy Can Predict The Effectiveness And Prognosis Of Chemotherapy." Medicine 98.42 (2019): e17335. Web.

  • Journal

    Zhao, Q., Yu, D. and Agrawal, S.

    Immunostimulatory activity of CpG containing phosphorothioate oligodeoxynucleotideis modulated by modificationof a single deoxynucleoside

    2000 - Elsevier

    In-text: (Zhao, Yu and Agrawal 1051-1054)

    Your Bibliography: Zhao, Qiuyan, Dong Yu, and Sudhir Agrawal. "Immunostimulatory Activity Of Cpg Containing Phosphorothioate Oligodeoxynucleotideis Modulated By Modificationof A Single Deoxynucleoside." Elsevier 10.10 (2000): 1051-1054. Web. 18 Nov. 2019.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Quick and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies